Prognostic variables in patients who have undergone radical cystectomy for transitional cell carcinoma of the bladder

Japanese Journal of Clinical Oncology

Volumn 31, Issue 8, 2001, Pages 399-402

  Hara, Shoji ^a   Miyake, Hideaki ^a   Fujisawa, Masato ^a   Okada, Hiroshi ^a   Arakawa, Soichi ^a   Kamidono, Sadao ^a   Hara, Isao ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Radical cystectomy; Survival; Transitional cell carcinoma of the bladder

Indexed keywords

CISPLATIN DERIVATIVE;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BLADDER CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER INVASION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CORRELATION FUNCTION; CYSTECTOMY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INCIDENCE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PELVIS LYMPHADENECTOMY; PREDICTION; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TRANSITIONAL CELL CARCINOMA; VASCULAR DISEASE;

EID: 0034792821     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/hye086     Document Type: Article

References (19)

1. Prognostic factors of outcome after radical cystectomy for bladder cancer: A retrospective study of a homogeneous patient cohort
2. Urinary diversion-related outcome in patients with pelvic recurrence after radical cystectomy for bladder cancer
3. A stage specific approach to tumor surveillance after radical cystectomy for transitional cell carcinoma of the bladder
4. The effect of cystectomy and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancer
5. The relationship of local control to distant metastasis in muscle invasive bladder cancer
6. The rationale of en bloc pelvic node dissection for bladder cancer patients with nodal metastases: Long term results
7. The role of pelvic lymphadectomy for lymph node positive bladder cancer. The Memorial Sloan-Kettering Cancer Center experience
8. The value of pathological factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate
9. Elevation of serum level of vascular endothelial growth factor as a new predictor of recurrence and disease progression in patients with superficial urothelial cancer
10. Independent prognostic value of serum hepatocyte growth factor in bladder cancer
11. Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder
12. Increased angiogenin expression in the tumor tissue and serum in urothelial carcinoma patients is related to disease progression and recurrence
13. The angiogenic factor midkine is expressed in bladder cancer and overexpression correlates with a poor outcome in patients with invasive cancers
14. Radical cystectomy in regionally advanced bladder cancer
15. Preoperative adjuvant therapy for urinary bladder cancer
16. Long-term results of neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for locally invasive transitional cell carcinoma of the urothelium
17. Carcinoma of the urinary bladder: A pathological study with special references to invasiveness and vascular invasion
18. Invasive bladder cancer: Tumor configuration, lymphatic invasion and survival